Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
3.140
+1.060 (50.96%)
At close: Jun 5, 2025, 4:00 PM
4.570
+1.430 (45.54%)
Pre-market: Jun 6, 2025, 9:01 AM EDT
Eyenovia Employees
As of December 31, 2024, Eyenovia had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 43 or -75.44% compared to the previous year.
Employees
14
Change (1Y)
-43
Growth (1Y)
-75.44%
Revenue / Employee
$4,790
Profits / Employee
-$3,027,133
Market Cap
9.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
EYEN News
- 17 days ago - Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewsWire
- 2 months ago - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewsWire
- 3 months ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire
- 3 months ago - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewsWire
- 4 months ago - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewsWire
- 4 months ago - Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewsWire
- 5 months ago - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewsWire